201 related articles for article (PubMed ID: 34550619)
21. Potentials of long non-coding RNAs as biomarkers of colorectal cancer.
Lv Y; Wang Y; Zhang Z; Bao J; Su H
Clin Transl Oncol; 2022 Sep; 24(9):1715-1731. PubMed ID: 35581419
[TBL] [Abstract][Full Text] [Related]
22. Role of non-coding RNAs as novel biomarkers for detection of colorectal cancer progression through interaction with the cell signaling pathways.
Esmaeili M; Keshani M; Vakilian M; Esmaeili M; Peymani M; Seyed Forootan F; Chau TL; Göktuna SI; Zaker SR; Nasr Esfahani MH; Ghaedi K
Gene; 2020 Aug; 753():144796. PubMed ID: 32450203
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
Li X; Nie J; Mei Q; Han WD
World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
[TBL] [Abstract][Full Text] [Related]
24. An Updated Review of the Pre-Clinical Role of microRNAs and their Contribution to Colorectal Cancer.
Dastmalchi N; Safaralizadeh R; Teimourian S
Curr Mol Med; 2022; 22(10):851-859. PubMed ID: 34961460
[TBL] [Abstract][Full Text] [Related]
25. Expression profile, molecular functions, and prognostic significance of miRNAs in primary colorectal cancer stem cells.
Fan CW; Lu R; Fang C; Zhang XL; Lv ZY; Li Y; Zhang H; Zhou ZG; Mo XM; Sun XF
Aging (Albany NY); 2021 Apr; 13(8):12067-12085. PubMed ID: 33793420
[TBL] [Abstract][Full Text] [Related]
26. Emerging role of microRNA-21 in colorectal cancer.
Zhao J; Zhang Y; Zhao G
Cancer Biomark; 2015; 15(3):219-26. PubMed ID: 25769454
[TBL] [Abstract][Full Text] [Related]
27. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.
Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y
Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives.
Muhammad S; Kaur K; Huang R; Zhang Q; Kaur P; Yazdani HO; Bilal MU; Zheng J; Zheng L; Wang XS
World J Gastroenterol; 2014 Dec; 20(45):17011-9. PubMed ID: 25493013
[TBL] [Abstract][Full Text] [Related]
29. DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways.
Liu X; Chen X; Zeng K; Xu M; He B; Pan Y; Sun H; Pan B; Xu X; Xu T; Hu X; Wang S
Cell Death Dis; 2018 Oct; 9(10):1037. PubMed ID: 30305607
[TBL] [Abstract][Full Text] [Related]
30. Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer.
Rahmani F; Avan A; Hashemy SI; Hassanian SM
J Cell Physiol; 2018 Feb; 233(2):811-817. PubMed ID: 28266708
[TBL] [Abstract][Full Text] [Related]
31. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.
Hibner G; Kimsa-Furdzik M; Francuz T
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262723
[TBL] [Abstract][Full Text] [Related]
32. Identification of microRNAs and their Endonucleolytic Cleavaged target mRNAs in colorectal cancer.
Zhou F; Tang D; Xu Y; He H; Wu Y; Lin L; Dong J; Tan W; Dai Y
BMC Cancer; 2020 Mar; 20(1):242. PubMed ID: 32293320
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs targeting EGFR signalling pathway in colorectal cancer.
Mlcochova J; Faltejskova P; Nemecek R; Svoboda M; Slaby O
J Cancer Res Clin Oncol; 2013 Oct; 139(10):1615-24. PubMed ID: 23817698
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer.
Cekaite L; Eide PW; Lind GE; Skotheim RI; Lothe RA
Oncotarget; 2016 Feb; 7(6):6476-505. PubMed ID: 26623728
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs and colorectal cancer: clinical potential and regulatory networks.
Osei GY; Adu-Amankwaah J; Koomson S; Beletaa S; Asiamah EA; Smith-Togobo C; Razak SRA
Mol Biol Rep; 2023 Nov; 50(11):9575-9585. PubMed ID: 37776413
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Value Investigation and Bioinformatics Analysis of miR-31 in Patients with Lymph Node Metastasis of Colorectal Cancer.
Zhang WW; Ming XL; Rong Y; Huang CQ; Weng H; Chen H; Bian JM; Wang FB
Anal Cell Pathol (Amst); 2019; 2019():9740475. PubMed ID: 31934534
[TBL] [Abstract][Full Text] [Related]
37. miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review.
Elrebehy MA; Al-Saeed S; Gamal S; El-Sayed A; Ahmed AA; Waheed O; Ismail A; El-Mahdy HA; Sallam AM; Doghish AS
Int J Biol Macromol; 2022 Aug; 214():583-600. PubMed ID: 35768045
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs in colorectal cancer: potential biomarkers and therapeutic targets.
Yan S; Cao Y; Mao A
Front Biosci (Landmark Ed); 2015 Jun; 20(7):1092-103. PubMed ID: 25961547
[TBL] [Abstract][Full Text] [Related]
39. Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.
Yang Y; Du Y; Liu X; Cho WC
Adv Exp Med Biol; 2016; 937():19-51. PubMed ID: 27573893
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs as potential therapeutic targets to predict responses to oxaliplatin in colorectal cancer: From basic evidence to therapeutic implication.
Moradi Marjaneh R; Khazaei M; Ferns GA; Avan A; Aghaee-Bakhtiari SH
IUBMB Life; 2019 Oct; 71(10):1428-1441. PubMed ID: 31322820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
